Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program
Go back to Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.65 -0.07 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.72 | 52 Week High | $5.58 | |||
| Open | $14.65 | 52 Week Low | $3.60 | |||
| Day High | $14.68 | P/E | N/A | |||
| Day Low | $14.54 | EPS | $0.00 | |||
| Volume | 9,073,061 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 45.83 +0.14 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.69 | 52 Week High | $44.76 | |||
| Open | $45.73 | 52 Week Low | $36.81 | |||
| Day High | $45.98 | P/E | N/A | |||
| Day Low | $45.57 | EPS | $0.00 | |||
| Volume | 809,013 | |||||
